Ignite Creation Date:
2024-05-06 @ 7:07 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05909618
Status:
RECRUITING
Last Update Posted:
2023-11-28
First Post:
2023-05-01
Brief Title:
Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
Sponsor:
Sheba Medical Center
Organization:
Sheba Medical Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| MGMT-Unmethylated Glioblastoma |
| Advanced Glioblastoma |
| Metastatic Melanoma in the Central Nervous System |
Keywords: